Chemoinformaics analysis of 2,3-dihydroxy-1,4-naphthoquinone
Molecular Weight | 190.154 | nRot | 0 |
Heavy Atom Molecular Weight | 184.106 | nRig | 14 |
Exact Molecular Weight | 190.027 | nRing | 2 |
Solubility: LogS | -2.818 | nHRing | 0 |
Solubility: LogP | 0.546 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 23.9088 |
nHD | 2 | BPOL | 7.75524 |
QED | 0.461 |
Synth | 2.743 |
Natural Product Likeliness | 0.685 |
NR-PPAR-gamma | 0.071 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.011 |
Pgp-sub | 0.001 |
HIA | 0.009 |
CACO-2 | -4.819 |
MDCK | 0.0000206 |
BBB | 0.604 |
PPB | 0.732821 |
VDSS | 0.151 |
FU | 0.131824 |
CYP1A2-inh | 0.66 |
CYP1A2-sub | 0.095 |
CYP2c19-inh | 0.101 |
CYP2c19-sub | 0.084 |
CYP2c9-inh | 0.05 |
CYP2c9-sub | 0.24 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.269 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.194 |
CL | 0.951 |
T12 | 0.44 |
hERG | 0.008 |
Ames | 0.533 |
ROA | 0.064 |
SkinSen | 0.696 |
Carcinogencity | 0.02 |
EI | 0.762 |
Respiratory | 0.527 |
NR-Aromatase | 0.034 |
Antiviral | No |
Prediction | 0.797225 |